SEC 13F Intelligence

Morgan Jess S & Co Inc / AXSM

Morgan Jess S & Co Inc’s Axsome Therapeutics Inc. Position

Does Morgan Jess S & Co Inc own Axsome Therapeutics Inc. (AXSM)? Yes — 78.9K shares worth $4M (+3.06% of its 13F portfolio) as of Q3 2022, down from 104.9K shares the prior filed quarter.

Position Value
$4M
Q3 2022
Shares
78.9K
% of Portfolio
+3.06%
Quarters Held
5
currently held

Position History AXSM

Reported value by quarter
Q3 ’21: $5MQ3 ’21Q4 ’21: $4MQ4 ’21Q1 ’22: $4MQ1 ’22Q2 ’22: $4MQ2 ’22Q3 ’22: $4MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202278.9K$4M+3.06%
Q2 2022104.9K$4M+4.17%
Q1 2022107.2K$4M+3.23%
Q4 2021114.5K$4M+2.66%
Q3 202167.8K$5M+3.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Morgan Jess S & Co Inc’s full portfolio or all institutional holders of AXSM.